Business Context and Reporting Period
Company: NanoViricides, Inc. (NNVC)
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2024
Reporting Period: Events reported as of August 5, 2024, with employment extensions effective July 1, 2024.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes
The registrant entered into two employment extension agreements effective July 1, 2024:
- Dr. Anil R. Diwan (President):
- Term extended through June 30, 2025.
- Base annual salary set at $400,000.
- Granted 10,204 shares of Series A Preferred Stock (vesting schedule noted as commencing September 30, 2023, and fully vesting June 30, 2024).
- Term Life Insurance policy maintained at $2 million ($1 million assigned to Registrant, remainder to estate).
- Severance eligibility: 6 months' salary if terminated without cause.
- Meeta Vyas (Chief Financial Officer):
- Term extended for one year through June 30, 2025 (renewable annually).
- Base compensation remains $10,800 per month.
- Continued issuance of 129 shares of Series A preferred stock monthly.
- New benefit: Reimbursement of up to 50% of health insurance costs (Medical, Dental, Medicare), capped at $2,500 per month.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of material risks and contingencies beyond the standard terms of the employment contracts.
Investor Verification Checklist
- Verify the current vesting status of the 10,204 Series A Preferred Stock shares granted to Dr. Diwan, as the text states they were to fully vest by June 30, 2024.
- Confirm the total outstanding Series A Preferred Stock to assess the dilution impact of the monthly grants to the CFO.
- Review the company's cash position to ensure liquidity is sufficient to support the $400,000 annual salary for the President and the new health insurance reimbursement cap for the CFO.
- Check for any prior filings regarding the "Diwan Employment Agreement" from 2018 to understand the historical compensation structure.